Financials

  • Market Capitalization 2.37 B
  • Employee 370
  • Founded 2016
  • CEO N/A
  • Website www.tarsusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RB9BNQ7
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-63.2
ratio cours/chiffre d'affaires
5.56

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1856
SLS
SELLAS Life Sciences Group, Inc. - Common Stock
13.60 USD+1.57%-6.98%+78.95%+608.33%2.53 B USD
1860
BCRX
BioCryst Pharmaceuticals, Inc. - Common Stock
9.45 USD-2.98%-12.26%+3.96%+8.00%2.40 B USD
1880
NRIX
Nurix Therapeutics, Inc. - Common stock
23.09 USD+0.48%-4.74%+36.39%+105.98%2.40 B USD
1884
AGIO
Agios Pharmaceuticals, Inc. - Common Stock
39.62 USD-0.75%-8.92%+23.89%-8.69%2.36 B USD

Nouvelles